Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CEST

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
10:11a SANOFI : and NIH chart early success with 3-part antibody against HIV
09/21 NEKTAR THERAPEUTICS (NASDAQ : NKTR) Files An 8-K Departure of Directors or Certa..
09/21 SANOFI : Researchers from Sanofi Report Recent Findings in Nanocrystals (New App..
09/21 REGENERON PHARMACEUTICALS : and Sanofi Announce Positive Dupilumab Topline Resul..
09/21 AGENDA RELEASED FOR THE HIGHLY ANTIC : Join, Pfizer, GSK, Sanofi and more
09/21 SANOFI : Alnylam Report Positive Topline Results From APOLLO Phase 3 Study of Pa..
09/21 SANOFI : Three-in-One Antibody Protects Monkeys From HIV-Like Virus
09/21 SANOFI : Kuehne + Nagel secures logistics contract from French drugmaker Sanofi
09/20 SANOFI : New kind of HIV antibody provides complete protection in monkey study
09/20 SANOFI : and NIH researchers develop "three-in-one" antibodies as a potential br..
More news
News from SeekingAlpha
09/21 Esperion Therapeutics Remains Undervalued
09/21 YOUR DAILY PHARMA SCOOP : Intercept's Buy Opportunity, Alcobra's Downfall, Shire..
09/21 3 THINGS IN BIOTECH YOU SHOULD LEARN : September 21, 2017
09/20 Sanofi teams with researchers to develop trispecific antibodies for HIV
09/20 NanoFlu Gives Novavax Room To Maneuver
Financials (€)
Sales 2017 36 340 M
EBIT 2017 9 641 M
Net income 2017 7 849 M
Debt 2017 5 108 M
Yield 2017 3,63%
P/E ratio 2017 13,62
P/E ratio 2018 17,73
EV / Sales 2017 3,05x
EV / Sales 2018 2,97x
Capitalization 106 B
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 86,5 €
Spread / Average Target 3,2%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias A. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI9.06%126 655
BAYER11.37%431 753
JOHNSON & JOHNSON15.63%357 562
NOVARTIS11.88%225 389
ROCHE HOLDING LTD.6.19%220 645
PFIZER10.81%214 325